Last Updated: August 2, 2026

Padagis Israel Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for PADAGIS ISRAEL

PADAGIS ISRAEL has eighty-one approved drugs.

There is one tentative approval on PADAGIS ISRAEL drugs.

Summary for Padagis Israel

US Patents:	0
Tradenames:	48
Ingredients:	48
NDAs:	81
Patent Litigation for Padagis Israel:	See patent lawsuits for Padagis Israel
PTAB Cases with Padagis Israel as petitioner:	See PTAB cases with Padagis Israel as petitioner

Drugs and US Patents for Padagis Israel

+ Get email alerts for changes to this table

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Padagis Israel	TAZAROTENE	tazarotene	LOTION;TOPICAL	215393-001	Jul 29, 2025		DISCN	No	No		⤷ Start Trial				⤷ Start Trial
Padagis Israel	BETAMETHASONE VALERATE	betamethasone valerate	AEROSOL, FOAM;TOPICAL	078337-001	Nov 26, 2012	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
Padagis Israel	SUMATRIPTAN	sumatriptan	SPRAY;NASAL	213465-001	Sep 21, 2020	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
Padagis Israel	CALCIPOTRIENE AND BETHAMETHASONE DIPROPIONATE	betamethasone dipropionate; calcipotriene	SUSPENSION;TOPICAL	212367-001	Sep 11, 2020		DISCN	No	No		⤷ Start Trial				⤷ Start Trial
Padagis Israel	ACYCLOVIR	acyclovir	OINTMENT;TOPICAL	205659-001	Feb 20, 2019		DISCN	No	No		⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Paragraph IV (Patent) Challenges for PADAGIS ISRAEL drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Vaginal Cream	2%	➤ Subscribe	2009-12-23

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.